Risk & Leverage

Georgia partners with NuHarbor Security to create a unified cyber defense, aiming to protect critical public services and citizen data across all agencies.

ITF Therapeutics will unveil 10 new data presentations on its Duchenne therapy, DUVYZAT, offering critical new insights on long-term safety and efficacy.

A 94% surge in water damage claims reveals a growing crisis, yet a new survey shows over half of Canadians plan no action to protect their homes.

Following strong financial results, Andrew Peller Limited sees its second board departure in a year, raising questions about governance and leadership stability.

Malaysian solar firm FGL faces delisting after a reverse stock split, meant to save its listing, backfired and wiped out its public share float.

Following decades of financial discipline, specialty insurer RLI Corp. has earned AM Best's highest rating, signaling unmatched stability to the market.

The bakery giant announced its 94th straight quarterly dividend, but a weak 2026 forecast and high payout ratio raise questions about its sustainability.

The REIT is offering a high 9.75% yield for new notes, but investors who refuse the swap could see their current protections vanish. A critical choice looms.

The miner posted a $2.9B free cash flow and a record $1.8B dividend payout, fueled by high gold prices and strategic growth in its 2025 earnings.

Ghana ratifies a major oil deal with Kosmos Energy until 2040, promising $2B in investment but raising questions about long-term financial and green goals.

With its 2025 results fresh, Green Plains will outline its strategy for high-value biorefining and renewable fuels at a key BofA conference.

Utah's BZI appoints a long-term veteran as President and rebrands key divisions, cementing its strategy for national growth through talent and innovation.

Facing shrinking margins and investor demands, healthcare leaders are ditching AI experiments for automation that delivers immediate financial lift and audit-ready results.

A new media giant is born in Southeast Europe, promising unprecedented editorial freedom. But can its star-studded board protect journalism from deep-rooted pressures?

Pharma giant AbbVie raises its dividend, backed by robust financials and a powerful drug pipeline that signals a thriving post-Humira growth era.

A new report warns that rapid AI adoption has created a vast, invisible risk landscape where cyber threats are outpacing organizations' ability to defend.

The cannabis giant's landmark debt deal signals new institutional confidence, but a high interest rate reveals the industry's costly reality.

With a pivotal data release on the horizon, Passage Bio heads to two major conferences. Can its dementia gene therapy program win over Wall Street?

Riding a wave of strong financial performance, the aerospace materials giant is boosting its buyback authorization to $620 million, underscoring its bullish outlook.

The nation's largest single-family landlord posts strong profits but faces slowing rent growth, shifting its strategy from buying homes to building them.